2026-10-14 https://api.researchdata.se/oai-pmh

oai:researchdata.se:2024-144/1 2024-06-17 subject:ssif:10207 subject:ssif:20603 subject:ssif:3 subject:ssif:30203 subject:ssif:30228 subject:ssif:102 subject:ssif:206 subject:ssif:302 subject:ssif:1 subject:ssif:2 principal:slug:uppsala-university

info:eu-repo/semantics/other http://purl.org/dc/dcmitype/Dataset https://doi.org/10.57804/epa0-8v59 Undetected cancer in clinical prostate biopsies Undetected cancer in clinical prostate biopsies https://orcid.org/0000-0001-6852-6605 https://orcid.org/0000-0002-4139-7003 https://orcid.org/0000-0001-5163-5821 0000-0002-1835-921X Pernilla Andersson 0009-0002-0666-8952 SCIENCE AND TECHNOLOGY VETENSKAP OCH TEKNOLOGI Information technology Informationsteknik Computer graphics and computer vision Datorgrafik och datorseende Medical Imaging Medicinsk bildvetenskap Medical and Health Sciences Medicin och hälsovetenskap Cancer and Oncology Cancer och onkologi Urology Urologi This dataset comprises digitized benign prostate hematoxilyn and eosin (H&E) biopsies from men with raised prostate-specific antigen (PSA) values. The biopsies were systematically taken from different locations in the prostate and were not guided by magnetic resonance imaging (MRI). The dataset includes paired samples from patients with comparable age and PSA levels, all initially diagnosed as benign but with different outcomes upon subsequent follow-ups and re-biopsies. While some patients remained cancer-free during eight years of follow-up, others were diagnosed with prostate cancer within the subsequent 30 months of follow-up. The final processed dataset includes 213 patients from northern Sweden, resulting in a total of 587 H&E prostate needle biopsies. Among these, 125 control patients with 333 biopsies exhibited no cancer development in eight years following the initial diagnosis. Conversely, 88 case patients with 254 biopsies were diagnosed with prostate cancer of various ISUP grades within the 30 months following the initial diagnosis. Each case patient is accompanied by one to three control patients, paired for similar age, PSA value and year of diagnosis. Patients were anonymized by assigning random case IDs and MRXS image files were anonymized by using the module in https://github.com/bgilbert/anonymize-slide. Datasetet består av digitiserade godartade prostata H&E-biopsier från män med förhöjda PSA-värden. För mer information, se beskrivning på engelska: This dataset comprises digitized benign prostate hematoxilyn and eosin (H&E) biopsies from men with raised prostate-specific antigen (PSA) values. The biopsies were systematically taken from different locations in the prostate and were not guided by magnetic resonance imaging (MRI). The dataset includes paired samples from patients with comparable age and PSA levels, all initially diagnosed as benign but with different outcomes upon subsequent follow-ups and re-biopsies. While some patients remained cancer-free during eight years of follow-up, others were diagnosed with prostate cancer within the subsequent 30 months of follow-up. The final processed dataset includes 213 patients from northern Sweden, resulting in a total of 587 H&E prostate needle biopsies. Among these, 125 control patients with 333 biopsies exhibited no cancer development in eight years following the initial diagnosis. Conversely, 88 case patients with 254 biopsies were diagnosed with PCa of various ISUP grades within the 30 months following the initial diagnosis. Each case patient is accompanied by one to three control patients, paired for similar age, PSA value and year of diagnosis. Patients were anonymized by assigning random case IDs and MRXS image files were anonymized by using the module in https://github.com/bgilbert/anonymize-slide. info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/4.0/ Uppsala University Uppsala universitet 2024-06-17T15:05:09.849467Z eng